Search For

Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease

Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge

Obesity and diabetes in heart disease in women

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

Hypogonadism: cardiometabolism and gonadal function in men

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Exploring the role of testosterone upon adiposity and cardiovascular risk markers in men with severe obesity

Commentary: Of women, liver, and heart

New antidiabetic drugs' role in the management of testosterone deficiency and of the cardiovascular disease in hypogonadal diabetic men

Pharmacological management of type 2 diabetes: clinical considerations and future perspectives

Cardiovascular outcome trials of GLP-1RAs and SGLT-2 inhibitors: a concise review from the clinicians' perspective

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality